Mounjaro®
Starting from £179.99/mo
Start journey Learn morePersistent nausea on Mounjaro is one of the most commonly reported experiences in the first weeks of treatment. It happens because tirzepatide slows the rate at which your stomach empties, and your gut needs time to adjust to that change. Most people find the nausea settles — though when you're in the middle of it, that can feel very hard to believe. These are well-documented side effects of Mounjaro that featured in clinical trials, and they are not a sign that something has gone wrong with your body. Mounjaro is a prescription-only medicine; a prescriber reviews every aspect of your treatment, including how you're tolerating it, before your care continues.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The queasiness is a direct consequence of how tirzepatide works. As a dual GIP and GLP-1 receptor agonist, it acts on gut-hormone pathways that govern both appetite and digestion. One of its effects is delayed gastric emptying, your stomach processes food more slowly than it used to. That slowdown reduces hunger and helps create the calorie deficit that drives weight loss, but it also means food sits in your stomach for longer. When the stomach is still part-full and you eat again, or when the system is simply adapting to a new signal, nausea is the result.
The effect is strongest in the early weeks of treatment and tends to spike after each dose increase, which is exactly why the titration schedule is designed the way it is. Starting at 2.5 mg gives your digestive system a chance to adapt before the dose climbs. For many people the nausea eases noticeably between weeks two and four of a given dose. Nausea on Mounjaro is not the same for everyone: some barely notice it; others find it hard to function for a few days after each pen change. Both are within the range of reported experience.
The NHS medicines page for tirzepatide lists nausea among the most common side effects, alongside vomiting, diarrhoea, constipation, indigestion and burping. These tend to travel together in the early phase of treatment, though not everyone gets all of them.
For the large majority of people, yes. The nausea is almost always worst in the weeks after starting or after a dose step-up, and it usually becomes much more manageable once your body has had four to six weeks at a stable dose. That is not the same as saying it disappears entirely for everyone, some people experience low-level queasiness throughout treatment, particularly in the hours after injecting.
A few things reliably make it worse: eating large meals, eating high-fat or very rich food, eating too quickly, lying down shortly after eating, or drinking a lot at once with a meal. Small, slow meals with plenty of protein tend to sit better. Staying well hydrated between meals matters too, because dehydration compounds nausea rather than resolving it.
If the sickness feels particularly severe (vomiting you can't keep on top of, or nausea that makes eating or drinking anything impossible) contact your prescriber. Prolonged vomiting can cause dehydration and, in some cases, kidney strain, so it should not simply be waited out. Your prescriber may discuss slowing down the titration schedule, which is a legitimate and commonly used approach. If you are feeling sick after your Mounjaro injection specifically, there is more detail on what that pattern typically means and what tends to help. You can also read about practical steps to reduce nausea on Mounjaro that sit within what is known to help.
Ordinary Mounjaro nausea is unpleasant but does not usually include severe pain. If you develop intense, persistent stomach pain (especially pain that seems to radiate through to your back, with or without vomiting) that is a different situation. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines drawing attention to acute pancreatitis as an infrequent but serious side effect; you can report any suspected side effect via the Yellow Card scheme. Pancreatitis is not the same as feeling sick after a meal: the pain is typically severe and does not settle on its own. It requires urgent medical attention, not a wait-and-see approach.
Other symptoms that should prompt a call to your prescriber rather than quiet endurance include: signs of dehydration (dizziness, very dark urine, barely urinating), gallbladder-type pain on the right side of the abdomen, or any allergic reaction symptoms such as swelling of the face, lips or throat. The NHS patient information for tirzepatide sets out when to seek urgent help; it is worth reading the full list when you start treatment rather than after something concerns you.
Before stopping, talk to your prescriber. It is one of the most common conversations in weight-management care and there are real options beyond simply carrying on or giving up. Slowing the titration (spending longer at the current dose before stepping up) reduces the intensity of side effects for many people without compromising the long-term effectiveness of treatment. That decision belongs with your clinical team, not with a self-adjusted schedule.
If you are in the early stages and genuinely struggling, it also helps to know that the nausea rarely stays at its worst level. The first few weeks at each new dose are typically the hardest. If you are considering whether the treatment is working financially as well as physically, the Mounjaro pricing page sets out what a full month of treatment covers with a private prescription. For a broader look at weight-loss treatment options, including how Mounjaro sits alongside other licensed medicines, that overview may also be useful.
If you want our prescribers to review how you are tolerating treatment or to discuss whether a different approach suits you better, you can speak to our prescribers through a free consultation. Every review is done by a GPhC-registered Independent Prescriber, a real clinician who reads your case, not a form that routes you to a standard reply.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.